Cite
Long-term outcome of targeted therapy of underlying conditions in patients with early persistent atrial fibrillation and heart failure: data of the RACE 3 trial
MLA
Nguyen, B. O., et al. “Long-Term Outcome of Targeted Therapy of Underlying Conditions in Patients with Early Persistent Atrial Fibrillation and Heart Failure: Data of the RACE 3 Trial.” Europace, 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1366905604&authtype=sso&custid=ns315887.
APA
Nguyen, B. O., Crijns, H., Tijssen, J. G., Geelhoed, B., Hobbelt, A. H., Hemels, M. E. W., Mol, W. J. M., Weijs, B., Alings, M., Smit, M. D., Tieleman, R. G., Tukkie, R., Veldhuisen, D. J. van, Gelder, I. . van, & Rienstra, M. (2022). Long-term outcome of targeted therapy of underlying conditions in patients with early persistent atrial fibrillation and heart failure: data of the RACE 3 trial. Europace.
Chicago
Nguyen, B.O., H. Crijns, J.G. Tijssen, B. Geelhoed, A.H. Hobbelt, M.E.W. Hemels, W.J.M. Mol, et al. 2022. “Long-Term Outcome of Targeted Therapy of Underlying Conditions in Patients with Early Persistent Atrial Fibrillation and Heart Failure: Data of the RACE 3 Trial.” Europace. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1366905604&authtype=sso&custid=ns315887.